Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Micrologix completes phase I trial for prevention of bloodstream infections

May 3, 1999

NDA filed for first oral neuraminidase inhibitor for the flu

April 30, 1999

New oxazolidinones claimed by Zeneca (AstraZeneca)

April 30, 1999

Chinese investigators develop new antimicrobial agents

April 28, 1999

Pentose and Cangene enter licensing agreement

April 26, 1999

Abbott obtains marketing rights to Meiji cephalosporin in several major markets

April 23, 1999

Immunotherapeutic method of treating viral respiratory disease available from NIH

April 23, 1999

Amoxil cleared for b.i.d. dosing in children

April 22, 1999

Oxazolidinones useful for resistant Gram-positive infections

April 22, 1999

Genelabs and SmithKline Beecham share DARPA grant for drug development

April 22, 1999

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...